Pterostilbene raised LDL cholesterol by 17.1 mg/dL in the best human RCT (Riche 2014, n=80, P=0.001). The sirtuin/longevity claim has not translated to demonstrated human clinical benefit. Vanguard's revised position: we do not recommend oral pterostilbene supplementation.